FDA Approves Ketamine-Derived Treatment for Depression, But How Are People Really Using It? A Conversation with Kellye Greene of New York DanceSafe
On March 5, 2019, the FDA approved Spravato (esketamine), an intranasal spray for...
Read MoreSelect Page
Posted by Alexander Lekhtman | Mar 30, 2019 | Interviews |
On March 5, 2019, the FDA approved Spravato (esketamine), an intranasal spray for...
Read MorePosted by David Wilder | Mar 29, 2019 | Articles |
Anxiety and depression are common mental health conditions that negatively impact one’s quality of...
Read MorePosted by David Wilder | Jan 18, 2019 | Articles |
Formerly known only to the underground psychedelic community, the practice of taking microdoses of...
Read MorePosted by Alexander Lekhtman | Nov 13, 2018 | Articles |
On October 23, 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
Read MorePosted by David Wilder | Nov 12, 2018 | Articles |
People suffering from psychotic disorders often self-medicate with cannabis. While they may enjoy...
Read MoreJoin our mailing list to receive the latest news from the psychedelic world.